Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 769K) PPT slides of all figures Alert me when this article is cited Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by von Herrath, M. G. Articles by Nepom, G. T. Search for Related Content PubMed PubMed Citation Articles by von Herrath, M. G. Articles by Nepom, G. T. Social Bookmarking                            What's this?

Matthias G. von Herrath^a,b and Gerald T. Nepom^a,b

^a M.G.v.H. is at La Jolla Institute for Allergy and Immunology, San Diego, CA 92109.
^b G.T.N. is at Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.

CORRESPONDENCE M.G.v.H.: Matthias{at}liai.org

Abstract
Induction of selective, autoantigen-specific tolerance is the "holy grail" for the treatment and prevention of autoimmune diseases. Despite successes in many differential murine models, rational and efficient translation to the clinic has been difficult. During the 5th Annual Federation of Clinical Immunological Societies (FOCIS) Meeting, May 12–16, 2005, in Boston, MA, a Kirin-sponsored "Ideashop" was convened to discuss this theme amongst scientists, clinicians, industry partners, and funding agencies.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

• Piaggio, E., Mars, L. T., Cassan, C., Cabarrocas, J., Hofstatter, M., Desbois, S., Bergereau, E., Rotzschke, O., Falk, K., Liblau, R. S. (2007). Multimerized T cell epitopes protect from experimental autoimmune diabetes by inducing dominant tolerance. Proc. Natl. Acad. Sci. USA 104: 9393-9398 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS